Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Antoniolli

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Mini Reviews in Medicinal Chemistry|February 26, 2026
Chalcones as Multi-target Ligands for Alzheimer's Disease: A Review of Synthetic Strategies and Therapeutic PromiseGiorgio Antoniolli
Future Medicinal Chemistry|May 30, 2025
Recent advances in the investigation of the quinazoline nucleus and derivatives with potential anticancer activitiesGiorgio Antoniolli, Carmen Silvia Passos Lima, Fernando Coelho
Current Medicinal Chemistry|October 21, 2020
Chalcones Acting as Inhibitors of Cholinesterases, β-Secretase and β- Amyloid Aggregation and other Targets for Alzheimer's Disease: A Critical ReviewGiorgio Antoniolli, Wanda P Almeida, Camila C Frias, et al.
Bioorganic Chemistry|September 5, 2020
Synthesis and biological evaluation of 2'-Aminochalcone: A multi-target approach to find drug candidates to treat Alzheimer's diseaseRenata P Sakata, Giorgio Antoniolli, Marcelo Lancellotti, et al.
Tissue & Cell|September 10, 2025
Cirsiliol confers cardio-protection against sunitinib induced cardiotoxicity via synergistic modulation of SIRT1/FOXO3a and endothelin axis: A biochemical, histopathological, and computational experimentationMahmoud El Safadi, Abdulaziz Saleh Alkhoshaiban, Hafsa Ashfaq, et al.
ACS Omega|August 18, 2025
Synthesis and Evaluation of 2‑Substituted Quinazolin-4(3<i>H</i>)‑ones as Potential Antileukemic AgentsGiorgio Antoniolli, Keli Lima, Gilberto Carlos Franchi, et al.
Archiv Der Pharmazie|August 21, 2025
Advances in Xanthine Oxidase Inhibition: A Review of Potential Bioactive Synthetic CompoundsGiorgio Antoniolli, Gabriel Rodrigues de Moraes, Rafael Porreca Neves da Costa, et al.
Tissue & Cell|November 27, 2024
Pharmacotherapeutic potential of pratensein to avert metribuzin instigated hepatotoxicity via regulating TGF-β1, PI3K/Akt, Nrf-2/Keap-1 and NF-κB pathwayHesham M Hassan, Mahmoud El Safadi, Warda Mustfa, et al.
Toxicon : Official Journal of the International Society on Toxinology|September 12, 2025
Melanoxetin modulates oxidative, inflammatory and apoptotic pathways to confer cardio-protection against flumethrin-induced sub-chronic toxicityHesham M Hassan, Aqsa Bibi, Giorgio Antoniolli, et al.
Pesticide Biochemistry and Physiology|October 30, 2024
Palliative potential of velutin against abamectin induced cardiac toxicity via regulating JAK1/STAT3, NF-κB, Nrf-2/Keap-1 signaling pathways: An insight from molecular dockingMahmoud El Safadi, Qurat-Ul-Ain Ahmad, Muhammad Majeebullah, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Mini Reviews in Medicinal Chemistry|February 26, 2026
Chalcones as Multi-target Ligands for Alzheimer's Disease: A Review of Synthetic Strategies and Therapeutic PromiseGiorgio Antoniolli
Future Medicinal Chemistry|May 30, 2025
Recent advances in the investigation of the quinazoline nucleus and derivatives with potential anticancer activitiesGiorgio Antoniolli, Carmen Silvia Passos Lima, Fernando Coelho
Current Medicinal Chemistry|October 21, 2020
Chalcones Acting as Inhibitors of Cholinesterases, β-Secretase and β- Amyloid Aggregation and other Targets for Alzheimer's Disease: A Critical ReviewGiorgio Antoniolli, Wanda P Almeida, Camila C Frias, et al.
Bioorganic Chemistry|September 5, 2020
Synthesis and biological evaluation of 2'-Aminochalcone: A multi-target approach to find drug candidates to treat Alzheimer's diseaseRenata P Sakata, Giorgio Antoniolli, Marcelo Lancellotti, et al.
Tissue & Cell|September 10, 2025
Cirsiliol confers cardio-protection against sunitinib induced cardiotoxicity via synergistic modulation of SIRT1/FOXO3a and endothelin axis: A biochemical, histopathological, and computational experimentationMahmoud El Safadi, Abdulaziz Saleh Alkhoshaiban, Hafsa Ashfaq, et al.
ACS Omega|August 18, 2025
Synthesis and Evaluation of 2‑Substituted Quinazolin-4(3<i>H</i>)‑ones as Potential Antileukemic AgentsGiorgio Antoniolli, Keli Lima, Gilberto Carlos Franchi, et al.
Archiv Der Pharmazie|August 21, 2025
Advances in Xanthine Oxidase Inhibition: A Review of Potential Bioactive Synthetic CompoundsGiorgio Antoniolli, Gabriel Rodrigues de Moraes, Rafael Porreca Neves da Costa, et al.
Tissue & Cell|November 27, 2024
Pharmacotherapeutic potential of pratensein to avert metribuzin instigated hepatotoxicity via regulating TGF-β1, PI3K/Akt, Nrf-2/Keap-1 and NF-κB pathwayHesham M Hassan, Mahmoud El Safadi, Warda Mustfa, et al.
Toxicon : Official Journal of the International Society on Toxinology|September 12, 2025
Melanoxetin modulates oxidative, inflammatory and apoptotic pathways to confer cardio-protection against flumethrin-induced sub-chronic toxicityHesham M Hassan, Aqsa Bibi, Giorgio Antoniolli, et al.
Pesticide Biochemistry and Physiology|October 30, 2024
Palliative potential of velutin against abamectin induced cardiac toxicity via regulating JAK1/STAT3, NF-κB, Nrf-2/Keap-1 signaling pathways: An insight from molecular dockingMahmoud El Safadi, Qurat-Ul-Ain Ahmad, Muhammad Majeebullah, et al.
Pageof 2